First Patient Enrolled in SELUTION SLR IDE BTK Study
The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, just one week after receiving IDE approval. “I am excited to begin an important trial which will establish the evidence that this novel technology benefit patients suffering from CLTI,” commented Dr. Michael Lichtenberg, […]
